Interestingly, αvβ6-neutralizing antibody 264RAD has been reported to suppress TGFβ signaling and reduce tumor growth in an αvβ6-positive human pancreatic ductal adenocarcinoma (PDAC) xenografts mice model [133]. The gene discussed is TGFB1; the disease is pancreatic ductal adenocarcinoma.